Cargando…
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy
According to the current international guidelines, high‐risk patients diagnosed with pathological T1 (pT1) colorectal cancer (CRC) who underwent complete local resection but may have risk of developing lymph node metastasis (LNM) are recommended additional intestinal resection with lymph node dissec...
Autores principales: | Miyo, Masaaki, Kato, Takeshi, Nakamura, Yoshiaki, Taniguchi, Hiroya, Takahashi, Yusuke, Ishii, Masayuki, Okita, Kenji, Ando, Koji, Yukami, Hiroki, Mishima, Saori, Yamazaki, Kentaro, Kotaka, Masahito, Watanabe, Jun, Oba, Koji, Aleshin, Alexey, Billings, Paul R., Rabinowitz, Matthew, Kotani, Daisuke, Oki, Eiji, Takemasa, Ichiro, Mori, Masaki, Yoshino, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990725/ https://www.ncbi.nlm.nih.gov/pubmed/34839585 http://dx.doi.org/10.1111/cas.15226 |
Ejemplares similares
-
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
por: Taniguchi, Hiroya, et al.
Publicado: (2021) -
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2023) -
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer
por: Miyo, Masaaki, et al.
Publicado: (2020) -
Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
por: Oki, Eiji, et al.
Publicado: (2021) -
Short‐term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE‐1)
por: Kagawa, Yoshinori, et al.
Publicado: (2023)